Your session is about to expire
← Back to Search
Biopsy Needle
VMCore Biopsy System for Prostate Cancer
N/A
Waitlist Available
Research Sponsored by Uro-1 Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day of the procedure
Awards & highlights
Study Summary
This study is evaluating whether the VMCore biopsy needle captures more tissue than standard of care needles.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day of the procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day of the procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse Events
Patient Pain During use of the biopsy needles
Procedure Success
Secondary outcome measures
Mean Tissue volume for each sample taken
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VMCore Biopsy SystemExperimental Treatment1 Intervention
The VMCore biopsy needle will used to collect up to 10 tissue samples.
Group II: Standard of Care Biopsy NeedleActive Control1 Intervention
The urologist will use his/her standard biopsy needle to collect up to 15 tissue samples.
Find a Location
Who is running the clinical trial?
Uro-1 MedicalLead Sponsor
2 Previous Clinical Trials
90 Total Patients Enrolled
Thomas LawsonStudy DirectorUro-1 Medical
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger